BMS-986446 receives FDA fast track designation for alzheimer's treatment
Go back to BMS-986446 receives FDA fast track designation for alzheimer's treatment| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 66.95 +0.14 (0.21%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.81 | 52 Week High | $77.12 | |||
| Open | $67.58 | 52 Week Low | $49.03 | |||
| Day High | $68.04 | P/E | 43.47 | |||
| Day Low | $66.91 | EPS | $1.54 | |||
| Volume | 597,948 | |||||
| PROTHENA CORP (NASDAQ: PRTA) | Delayed: 9.36 +0.01 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.35 | 52 Week High | $76.42 | |||
| Open | $9.28 | 52 Week Low | $28.20 | |||
| Day High | $9.39 | P/E | N/A | |||
| Day Low | $9.26 | EPS | $-2.84 | |||
| Volume | 19,851 | |||||
